驗證網址www.biosciencetechnology.com安全性

Embryonic Stem Cells in Trial for Diabetes

As San Diego’s ViaCyte was in the midst of launching the first FDA-approved embryonic stem (ES) cell clinical trial for diabetes last week, Boston’s Harvard University reported that beta cells from ES cells “cured” diabetic mouse-models. Both teams worked...

網址安全性掃描由 google 提供